
AdaptHealth Corp (AHCO) Stock Forecast & Price Target
AdaptHealth Corp (AHCO) Analyst Ratings
Bulls say
AdaptHealth is poised to continue its strong performance in its primary segment, Sleep Health, while also seeing growth and progress in its other segments, particularly in Respiratory and Diabetes. The company's focus on providing patient-centered, healthcare-at-home solutions puts it in a prime position to benefit from the current trend of shifting healthcare services to the home. With strong visibility into labor cost normalization, continued expansion of cross-selling opportunities, and a robust capitated pipeline, we believe AdaptHealth has the potential for significant margin expansion and long-term growth.
Bears say
AdaptHealth is an innovative leader in the DME industry and has first-mover advantages, but potential for disruption to operations and reimbursement pressure from government and third-party payors pose major risks. Despite steady revenue growth in its Sleep Health segment, the company's adjusted EBITDA for 2026 and 2027 may fall below previous estimates, leading to a lowered price target of $12 (from $13). Additionally, potential regulatory issues and economic downturn could impact demand and patient payment ability.
This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.
AdaptHealth Corp (AHCO) Analyst Forecast & Price Prediction
Start investing in AdaptHealth Corp (AHCO)
Order type
Buy in
Order amount
Est. shares
0 shares